Press Releases

Read the latest press releases from 10xBio.

10xBio Announces the Completion of Phase 1B Clinical Trial of 10XB101

SAN DIEGO (May 6, 2019) – 10xBio, LLC, a privately-held biotechnology company, announced today that it has completed a Phase 1B study of its novel injectable drug product for body contouring. The company’s drug product 10XB101 is a novel formulation of polidocanol which is approved in the U.S….

read more

10xBio Completes Series A Financing

SAN DIEGO (April 2, 2018) – 10xBio, LLC, a privately-held biotechnology company, completed a Series A financing from a select group of partners and private investors during the first quarter of 2018. Capital raised totaled $2,660,000 including conversion of outstanding notes. Proceeds will be used to advance the company’s lead asset, 10XB101…

read more

10xBio Announces Issuance of U.S. Patent

SAN DIEGO (May 31, 2017) – 10xBio, LLC, a privately-held biotechnology company, announced today that it has been issued patent 9,351,945 from the U.S. Patent and Trademark Office.

read more